Search

Search Constraints

You searched for: Author/Creator Rice, M

Search Results

4. S78 Dupilumab reduces risk of severe exacerbations and improves FEV1 regardless of baseline disease severity in patients with uncontrolled, moderate-to-severe asthma: data from the phase 3 LIBERTY ASTHMA QUEST study. (December 2018)